tiprankstipranks
Trending News
More News >
Infant Bacterial Therapeutics AB (DE:9IB)
BERLIN:9IB
Advertisement

Infant Bacterial Therapeutics AB (9IB) Similar Stocks

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Infant Bacterial Therapeutics AB
€4.50
€60.74M
-55.93%
Xbrane Biopharma AB
€0.03
€39.83M
50.00%
0 Buy
0 Hold
0 Sell
Hold
Ascelia Pharma AB
€0.44
€50.75M
118.50%
Guard Therapeutics International AB
€1.96
€40.50M
-18.54%
Immunicum AB
€0.72
€37.20M
9.09%
0 Buy
1 Hold
0 Sell
Hold
Cantargia AB
€0.25
€69.09M
-12.14%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:9IB
Infant Bacterial Therapeutics AB
4.50
-5.70
-55.88%
DE:7XB
Xbrane Biopharma AB
0.03
<0.01
50.00%
DE:7ZA
Ascelia Pharma AB
0.44
0.24
120.00%
DE:5LH0
Guard Therapeutics International AB
1.96
-0.28
-12.50%
DE:1YG0
Immunicum AB
0.72
0.08
12.50%
DE:7V3
Cantargia AB
0.25
-0.06
-19.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis